Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrografin in Postoperative Small Bowel Obstruction
NCT00389116Phase 4Completed
- Sponsor
- Rouen University Hospital
- Start
- Nov 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of diatrizoate meglumine + diatrizoate sodium in small bowel obstruction (SBO) (2 arms), sponsored by Rouen University Hospital. Primary endpoint: Need for surgical management at 2 months. Started Nov 2006; status: completed.
02
Drugs
diatrizoate meglumine + diatrizoate sodium
03
Conditions
small bowel obstruction (SBO)
Beyond the preview
Go deeper on NCT00389116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389116.